Advertisement
Advertisement
U.S. Markets open in 1 hr 30 mins
Advertisement
Advertisement
Advertisement
Advertisement

Cryo-Cell International, Inc. (CCEL)

NYSE American - NYSE American Delayed Price. Currency in USD
4.0400-0.0487 (-1.19%)
At close: 04:00PM EST
Advertisement

Cryo-Cell International, Inc.

700 Brooker Creek Boulevard
Suite 1800
Oldsmar, FL 34677
United States
813 749 2100
https://www.cryo-cell.com

Sector(s)Healthcare
IndustryMedical Care Facilities
Full Time Employees83

Key Executives

NameTitlePayExercisedYear Born
Mr. David I. PortnoyChairman & Co-CEO1.22MN/A1963
Mr. Mark L. PortnoyCo-CEO & Director873.34kN/A1964
Ms. Jill M. TaymansCFO & VP of Fin.205.42kN/A1970
Mr. Oleg MikulinskyChief Information Officer326.35kN/A1973
Dr. Joanne Kurtzberg M.D.Medical Director and Member of Medical & Scientific Advisory BoardN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Corporate Governance

Cryo-Cell International, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement